RDY vs. SSO

Last updated Jun 4, 2026

RDY (Dr. Reddy's Laboratories Limited) is a stock, while SSO (ProShares Ultra S&P500) is Leveraged Equities fund tracking the S&P 500. Over the past 10 years, RDY returned 4.12%/yr vs 24.21%/yr for SSO. At a 0.36 correlation, their price movements are largely independent.

Performance

RDY vs. SSO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dr. Reddy's Laboratories Limited (RDY) and ProShares Ultra S&P500 (SSO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RDY achieves a -7.26% return, which is significantly lower than SSO's 19.37% return. Over the past 10 years, RDY has underperformed SSO with an annualized return of 4.12%, while SSO has yielded a comparatively higher 24.21% annualized return.

RDY

• 1D: -0.08%
• 1M: -2.47%
• YTD: -7.26%
• 6M: -7.86%
• 1Y: -10.63%
• 3Y*: 5.64%
• 5Y*: -1.06%
• 10Y*: 4.12%

SSO

• 1D: -1.40%
• 1M: 9.75%
• YTD: 19.37%
• 6M: 18.81%
• 1Y: 52.69%
• 3Y*: 37.56%
• 5Y*: 19.62%
• 10Y*: 24.21%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RDY vs. SSO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RDY Dr. Reddy's Laboratories Limited	-7.26%	-10.53%	14.13%	36.47%	-19.74%	-7.33%	76.80%	8.45%	0.37%	-16.46%
SSO ProShares Ultra S&P500	19.37%	26.19%	43.48%	46.65%	-38.98%	60.57%	21.54%	63.45%	-14.60%	44.35%

Correlation

The correlation between RDY and SSO is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.20
Correlation (3Y) Calculated over the trailing 3-year period	0.21
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (10Y) Calculated over the trailing 10-year period	0.28
Correlation (All Time) Calculated using the full available price history since Jun 22, 2006	0.36

The correlation between RDY and SSO shifts across timeframes, from 0.20 (1 year) to 0.36 (all time), reflecting how their relationship changes across market environments.

Return for Risk

RDY vs. SSO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RDY

RDY Risk / Return Rank: 22
RDY Sharpe Ratio Rank: 21
RDY Sortino Ratio Rank: 20
RDY Omega Ratio Rank: 20
RDY Calmar Ratio Rank: 24
RDY Martin Ratio Rank: 25

SSO

SSO Risk / Return Rank: 62
SSO Sharpe Ratio Rank: 66
SSO Sortino Ratio Rank: 59
SSO Omega Ratio Rank: 60
SSO Calmar Ratio Rank: 58
SSO Martin Ratio Rank: 68

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RDY vs. SSO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dr. Reddy's Laboratories Limited (RDY) and ProShares Ultra S&P500 (SSO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RDY	SSO	Difference
Sharpe ratio: Return per unit of total volatility	-0.45	2.25	-2.69
Sortino ratio: Return per unit of downside risk	-0.48	2.86	-3.34
Omega ratio: Gain probability vs. loss probability	0.94	1.38	-0.44
Calmar ratio: Return relative to maximum drawdown	-0.48	2.91	-3.39
Martin ratio: Return relative to average drawdown	-0.82	12.80	-13.62
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RDY vs. SSO - Sharpe Ratio Comparison

The current RDY Sharpe Ratio is -0.45, which is lower than the SSO Sharpe Ratio of 2.25. The chart below compares the historical Sharpe Ratios of RDY and SSO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RDY	SSO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.45	2.25	-2.69
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.05	0.59	-0.63
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.16	0.68	-0.52
Sharpe Ratio (All Time) Calculated using the full available price history	0.35	0.42	-0.06

Drawdowns

RDY vs. SSO - Drawdown Comparison

The maximum RDY drawdown since its inception was -60.62%, smaller than the maximum SSO drawdown of -84.67%. Use the drawdown chart below to compare losses from any high point for RDY and SSO.

Drawdown Indicators

	RDY	SSO	Difference
Max Drawdown Largest peak-to-trough decline	-60.62%	-84.67%	+24.05%
Max Drawdown (1Y) Largest decline over 1 year	-22.46%	-18.17%	-4.29%
Max Drawdown (3Y) Largest decline over 3 years	-26.61%	-35.21%	+8.60%
Max Drawdown (5Y) Largest decline over 5 years	-35.25%	-46.73%	+11.48%
Max Drawdown (10Y) Largest decline over 10 years	-47.13%	-59.34%	+12.21%
Current Drawdown Current decline from peak	-22.21%	-1.40%	-20.81%
Average Drawdown Average peak-to-trough decline	-21.93%	-19.57%	-2.36%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.00%	4.13%	+8.87%

Volatility

RDY vs. SSO - Volatility Comparison

Dr. Reddy's Laboratories Limited (RDY) has a higher volatility of 9.37% compared to ProShares Ultra S&P500 (SSO) at 5.66%. This indicates that RDY's price experiences larger fluctuations and is considered to be riskier than SSO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RDY	SSO	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.37%	5.66%	+3.71%
Volatility (6M) Calculated over the trailing 6-month period	17.46%	17.78%	-0.32%
Volatility (1Y) Calculated over the trailing 1-year period	23.79%	23.60%	+0.19%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.28%	33.65%	-10.37%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	26.60%	35.89%	-9.29%

Dividends

RDY vs. SSO - Dividend Comparison

RDY's dividend yield for the trailing twelve months is around 0.70%, more than SSO's 0.62% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RDY Dr. Reddy's Laboratories Limited	0.70%	0.65%	0.60%	1.39%	1.48%	1.04%	0.46%	0.71%	0.00%	0.78%	0.62%	0.63%
SSO ProShares Ultra S&P500	0.62%	0.68%	0.85%	0.18%	0.50%	0.18%	0.20%	0.50%	0.75%	0.39%	0.51%	0.63%

Frequently Asked Questions

Can I hold both RDY and SSO in my portfolio?

RDY and SSO have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RDY or SSO?

RDY has higher volatility (9.37%) compared to SSO (5.66%). In terms of maximum drawdown, RDY dropped -60.62% vs SSO's -84.67%.

Which has better risk-adjusted returns?

SSO currently has the higher Sharpe Ratio (2.25 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.